Strategies for characterization of drug metabolites using liquid chromatography-tandem mass spectrometry in conjunction with chemical derivatization and on-line H/D exchange approaches

被引:123
作者
Liu, DQ
Hop, CECA
机构
[1] GlaxoSmithKline, Analyt Sci, King Of Prussia, PA 19406 USA
[2] Pfizer Inc, Groton Labs, Groton, CT 06340 USA
关键词
LC-MS/MS; tandem mass spectrometry; metabolite identification; structural elucidation; H/D exchange; chemical derivatization; drug metabolism;
D O I
10.1016/j.jpba.2004.09.003
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Strategies using high performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) in conjunction with techniques such as chemical derivatization and on-line hydrogen/deuteriurn (H/D) exchange for structural elucidation of drug metabolites in crude samples are reviewed. Useful mass spectrometric scan techniques discussed include product ion scan, constant neutral-loss scan, precursor ion scan, multistage MSn, and accurate mass measurements. In biological systems, xenobiotics are transformed into metabolites, which usually involves introduction of one or more polar functional groups or removal or blockage of such structural moieties. Therefore, chemical derivatization strategies for determination of functional groups and on-line H/D exchange approaches for probing number of exchangeable hydrogens are powerful tools for structural elucidation of drug metabolites in drug metabolism studies. More importantly, these experiments can be carried out on crude samples in microscale, providing sufficient material for LC-MS/MS analysis. Therefore, labor intensive and technically challenging purification of low levels of drug metabolites from complex biological matrices can be avoided. It is the authors' conclusion that strategies such as chemical derivatization and on-line H/D exchange should be used more routinely in drug metabolism studies in order to facilitate metabolite identification. (C) 2004 Elsevier B.V. All rights rese.rved.
引用
收藏
页码:1 / 18
页数:18
相关论文
共 90 条
[31]   Quantitative determination of BMS-186716, a thiol compound, in rat plasma by high-performance liquid chromatography positive ion electrospray mass spectrometry after hydrolysis of the methyl acrylate adduct by the native esterases [J].
Jemal, M ;
Hawthorne, DJ .
JOURNAL OF CHROMATOGRAPHY B, 1997, 698 (1-2) :123-132
[32]   Quantitative determination of BMS186716, a thiol compound, in dog plasma by high-performance liquid chromatography-positive ion electrospray mass spectrometry after formation of the methyl acrylate adduct [J].
Jemal, M ;
Hawthorne, DJ .
JOURNAL OF CHROMATOGRAPHY B, 1997, 693 (01) :109-116
[33]  
Johnson DW, 1999, RAPID COMMUN MASS SP, V13, P2388, DOI 10.1002/(SICI)1097-0231(19991215)13:23<2388::AID-RCM803>3.0.CO
[34]  
2-X
[35]  
Johnson DW, 2000, RAPID COMMUN MASS SP, V14, P2019, DOI 10.1002/1097-0231(20001115)14:21<2019::AID-RCM121>3.0.CO
[36]  
2-2
[37]   Metabolism, pharmacokinetics, and excretion of a highly selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in human cytochrome P450 2D6 extensive and poor metabolizers [J].
Johnson, K ;
Shah, A ;
Jaw-Tsai, S ;
Baxter, J ;
Prakash, C .
DRUG METABOLISM AND DISPOSITION, 2003, 31 (01) :76-87
[38]  
Ju C, 1998, DRUG METAB DISPOS, V26, P676
[39]   Collision-induced dissociation of purine antiviral agents: mechanisms of ion formation using gas-phase hydrogen/deuterium exchange and electrospray ionization tandem mass spectrometry [J].
Kamel, AM ;
Munson, B .
EUROPEAN JOURNAL OF MASS SPECTROMETRY, 2004, 10 (02) :239-257
[40]   Identification of the degradation product of ezlopitant, a non-peptidic substance p antagonist receptor, by hydrogen deuterium exchange, electrospray ionization tandem mass spectrometry (ESI/MS/MS) and nuclear magnetic resonance (NMR) spectroscopy [J].
Kamel, AM ;
Zandi, KS ;
Massefski, WW .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 31 (06) :1211-1222